Developing a national 'low risk' febrile neutropenia framework for use in children and young people's cancer care

Support Care Cancer. 2013 May;21(5):1241-51. doi: 10.1007/s00520-012-1653-y. Epub 2012 Dec 20.

Abstract

Purpose: A Delphi study was undertaken to develop a framework guidance that would rationalise and standardise the care of children with febrile neutropenia (FNP) across the UK.

Methods: A mailed Delphi survey was undertaken with health professionals working in children's cancer units. The survey employed two rounds of feedback on 22 practice statements drawn from a systematic review of clinical evidence. Consensus was assumed for any statement where 80+ % of respondents indicated that they "agreed" or "strongly agreed".

Results: Consensus was reached on 21 of the 22 practice statements in round 1 that were categorised into six areas: definition of fever and neutropenia, initial management and choice of antibiotic, defining low-risk patients, strategy in low-risk patients and alternative approaches. Consensus could not be reached on whether patients needed to be afebrile to be suitable for discharge and the required length of outpatient antibiotic treatment.

Conclusions: A Delphi survey allowed the successful development of a national framework for identification and management of children with FNP. The use of an existing well-functioning professional network was key in this project's success.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Consensus
  • Data Collection
  • Delphi Technique
  • Fever / etiology
  • Fever / therapy*
  • Humans
  • Neoplasms / therapy*
  • Neutropenia / etiology
  • Neutropenia / therapy*
  • Practice Guidelines as Topic*
  • Risk Factors
  • Time Factors
  • United Kingdom

Substances

  • Anti-Bacterial Agents